Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects (NSERC partnered)

University of British Columbia

$356,025.00

Platform technology for blood diagnostics integrating microneedle blood sampling and quantum-dot based multiplexed assays

FY 2017-18

Summary
Blood is the most useful sample fluid for lab medicine and diagnostics. It is most often obtained by inserting a needle in a vein in the arm (venipuncture). In the US, over 2 billion venipunctures are performed annually and is a technique that requires skilled personnel. Venipuncture is often associated with pain, discomfort and bruising, and is most difficult in persons with small, fragile, or "deep" veins (e.g. obesity), in babies, and when repeated sampling is needed. We propose an alternative that will minimize discomfort and bruising, will not require highly skilled personnel, and will be safe and easy. Our project combines an array of tiny needles (microneedles) that can be placed as a "patch" on the surface of the skin to collect small amounts of blood. The microneedles cause little discomfort, have a very low risk of causing bruising, and can be applied by the patient or a non-medical person. As the blood is collected, it will flow into a "lab-on-a-chip-on-a-phone" device, where the blood tests will automatically be performed using new and highly sensitive fluorescent probes. These tests will include immunoassays for protein biomarkers associated with cardiovascular disease, partially in collaboration with our industry partner, as well as assays of the activities of blood coagulation factors. Results from this platform can be immediately and electronically sent to the patient and physician. This research builds on successful preliminary applications with the microneedle arrays and fluorescent probes separately. We will now further develop and combine these innovative methods for a much-needed medical use, make comparisons to the standard venipuncture approach, and ultimately plan to perform many tests simultaneously with the devices. The benefits over current methods will be substantial: a painless, safe and user-friendly way to draw and test blood, with rapid reporting of results to health professionals and patients.
Program
Collaborative Health Research Projects (NSERC partnered)
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
375964
Name
Stoeber Boris
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Platform technology for blood diagnostics integrating microneedle blood sampling and quantum-dot based multiplexed assays
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$356,025
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Biomedical Engineering; Biomedical Technology; Blood Clot Resisting Coating; Lab-On-A-Chip; Medical Equipment & Apparatus; Microfluidics; Quantum Dot Labelling; Thrombin Activity Testing
Abstract
Blood is the most useful sample fluid for lab medicine and diagnostics. It is most often obtained by inserting a needle in a vein in the arm (venipuncture). In the US, over 2 billion venipunctures are performed annually and is a technique that requires skilled personnel. Venipuncture is often associated with pain, discomfort and bruising, and is most difficult in persons with small, fragile, or "deep" veins (e.g. obesity), in babies, and when repeated sampling is needed. We propose an alternative that will minimize discomfort and bruising, will not require highly skilled personnel, and will be safe and easy. Our project combines an array of tiny needles (microneedles) that can be placed as a "patch" on the surface of the skin to collect small amounts of blood. The microneedles cause little discomfort, have a very low risk of causing bruising, and can be applied by the patient or a non-medical person. As the blood is collected, it will flow into a "lab-on-a-chip-on-a-phone" device, where the blood tests will automatically be performed using new and highly sensitive fluorescent probes. These tests will include immunoassays for protein biomarkers associated with cardiovascular disease, partially in collaboration with our industry partner, as well as assays of the activities of blood coagulation factors. Results from this platform can be immediately and electronically sent to the patient and physician. This research builds on successful preliminary applications with the microneedle arrays and fluorescent probes separately. We will now further develop and combine these innovative methods for a much-needed medical use, make comparisons to the standard venipuncture approach, and ultimately plan to perform many tests simultaneously with the devices. The benefits over current methods will be substantial: a painless, safe and user-friendly way to draw and test blood, with rapid reporting of results to health professionals and patients.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Stoeber, Boris; Staykov, Radoslav; Algar, Walter R; Conway, Edward M; Kizhakkedathu, Jayachandran N
Approvedterm
3 ans 0 mois
Cihrcontribution2
Major Initiatives #2~ $356,025~ $0~